Literature DB >> 6026100

Estimation of the secretion rate of thyrotropin in man.

W D Odell, R D Utiger, J F Wilber, P G Condliffe.   

Abstract

The plasma concentration of a pituitary hormone is determined by the rate of secretion, degradation, and the volume of distribution of that hormone. Using a radioimmunoassay for human thyrotropin (TSH) and human TSH-(131)I, we have estimated the rates of degradation and distribution of TSH in man and calculated the rate of secretion. Either 0.5 or 5 mug of TSH-(131)I with specific activities of 1 to 50 muc per mug was administered intravenously to 12 euthyroid subjects. Serial determinations were made of TSH-(131)I, and the half-time of disappearance (t((1/2))) was thus estimated. The average t((1/2)) in euthyroid subjects was 53.9 minutes with a volume of distribution averaging 5.8% of body weight. The mean endogenous plasma TSH concentration was 1.8 mmug per ml (2.7 muU per ml in terms of the human TSH reference standard A). The mean total TSH pool, excluding the pituitary, was 5.8 mug (8.7 mU). From these data the mean secretion rate of TSH in euthyroid man was calculated to be 110.1 mug per day (165.2 mU). Similar data were estimated for 3 mildly hypothyroid patients. The t((1/2)) were 75.1, 97.1, and 83.6 minutes, with a mean of 85.3 minutes (1.6 times normal). The mean TSH pool was 58.1 mug (10 times normal). The secretion rate was 688.7 mug per day (1,033.1 mU). In other hypothyroid patients, plasma TSH levels ranging from 6 to 230 mmug per ml (9 to 345 muU) have been found. If similar half-times and a normal distribution volume are assumed, the secretion rate of TSH in hypothyroid patients can be estimated to range from about 260 to 15,350 mug per day (390 to 23,025 mU) or from about 2 to 307 times normal. Therefore, the elevated plasma TSH levels found in hypothyroidism are a result of both slower degradation and increase in rate of secretion.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6026100      PMCID: PMC297099          DOI: 10.1172/JCI105601

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  SURVIVAL OF ENDOGENOUS HUMAN GROWTH HORMONE IN PLASMA.

Authors:  S M GLICK; J ROTH; E T LONERGAN
Journal:  J Clin Endocrinol Metab       Date:  1964-06       Impact factor: 5.958

2.  ESTIMATION OF THYROID-STIMULATING HORMONE (TSH) SECRETION RATES OF NEW HAMPSHIRE FOWLS.

Authors:  C E HENDRICH; C W TURNER
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

3.  Disappearance rate of exogenous thyroid-stimulating hormone (TSH) in man.

Authors:  J BAKKE; N LAWRENCE; S ROY
Journal:  J Clin Endocrinol Metab       Date:  1962-04       Impact factor: 5.958

4.  Studies on the chemistry and bioassay of thyrotropins from bovine pituitaries, transplantable pituitary tumors of mice, and blood plasma.

Authors:  R W BATES; P G CONDLIFFE
Journal:  Recent Prog Horm Res       Date:  1960

5.  Studies on the metabolism of thyrotropin.

Authors:  H A LEVEY; D H SOLOMON
Journal:  Endocrinology       Date:  1957-01       Impact factor: 4.736

6.  The distribution of injected heterologous thyrotrophic hormone in the rat.

Authors:  A A KASSENAAR; L D LAMEYER; A QUERIDO
Journal:  Acta Endocrinol (Copenh)       Date:  1956-01

7.  The turnover rate of serum albumin in man as measured by I131-tagged albumin.

Authors:  K STERLING
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808

8.  Disappearance rate of exogenous thyrotrophin from the blood of normal and hypophysectomized rats.

Authors:  S A D'ANGELO
Journal:  Endocrinology       Date:  1951-03       Impact factor: 4.736

9.  Radioimmunoassay of thyrotropin in human serum.

Authors:  W D Odell; J F Wilber; W E Paul
Journal:  J Clin Endocrinol Metab       Date:  1965-09       Impact factor: 5.958

10.  Melanocyte-stimulating activity in a transplantable mouse pituitary tumor.

Authors:  I I Geschwind; R A Huseby
Journal:  Endocrinology       Date:  1966-07       Impact factor: 4.736

View more
  19 in total

1.  The fate of radioiodinated sheep-growth hormone in intact and nephrectomized sheep.

Authors:  A L Wallace; B D Stacy; G D Thorburn
Journal:  Pflugers Arch       Date:  1972       Impact factor: 3.657

2.  Computer simulation for hormones related to primary thyropathy.

Authors:  T Hatakeyama; H Yagi
Journal:  Biol Cybern       Date:  1985       Impact factor: 2.086

3.  Neuroendocrine control of thyroid secretion in living systems: a feedback control system model.

Authors:  J J DiStefano; E B Stear
Journal:  Bull Math Biophys       Date:  1968-03

4.  Pulsatile secretion of thyrotropin in children.

Authors:  S Loche; V Cherubini; E Bartolotta; A Lampis; D Carta; P Tomasi; C Pintor
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

5.  Prophylaxis of recurrent goiter by high-dose L-thyroxine.

Authors:  P Goretzki; H D Roeher; G Horeyseck
Journal:  World J Surg       Date:  1981-11       Impact factor: 3.352

6.  A kinetic study on secretion and elimination of endogenous thyrotropin in the thyrotropin-releasing hormone test.

Authors:  I Tsukamoto; K Satoh; K Kojima; I Hino; Y Kawase; H Seo; T Miyamoto; N Hosokawa; S Matsuno; T Tsukamoto
Journal:  Ann Nucl Med       Date:  1989-03       Impact factor: 2.668

7.  Metabolic clearance and secretion rates of subunits of human thyrotropin.

Authors:  I A Kourides; R N Re; B D Weintraub; E C Ridgway; F Maloof
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

8.  Radioimmunoassay for human follicle-stimulating hormone: physiological studies.

Authors:  W D Odell; A F Parlow; C M Cargille; G T Ross
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

9.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

10.  Metabolic clearance rate of radioiodinated human calcitonin in man.

Authors:  R Ardaillou; P Sizonenko; A Meyrier; G Vallée; C Beaugas
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.